Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection.
Staphylococcus aureus is a frequent cause for serious, chronic and therapy-refractive infections in spite of susceptibility to antibiotics in vitro. In chronic infections, altered bacterial phenotypes, such as small colony variants (SCVs), have been found. Yet, it is largely unclear whether the ability to interconvert from the wild-type to the SCV phenotype is only a rare clinical and/or just laboratory phenomenon or is essential to sustain an infection. Here, we performed different long-term in vitro and in vivo infection models with S. aureus and we show that viable bacteria can persist within host cells and/or tissues for several weeks. Persistence induced bacterial phenotypic diversity, including SCV phenotypes, accompanied by changes in virulence factor expression and auxotrophism. However, the recovered SCV phenotypes were highly dynamic and rapidly reverted to the fully virulent wild-type form when leaving the intracellular location and infecting new cells. Our findings demonstrate that bacterial phenotype switching is an integral part of the infection process that enables the bacteria to hide inside host cells, which can be a reservoir for chronic and therapy-refractive infections.
Institute of Medical Microbiology, University Hospital of Münster, Münster, Germany.
Lorena
L
Tuchscherr
Eva
E
Medina
Muzaffar
M
Hussain
Wolfgang
W
Völker
Vanessa
V
Heitmann
Silke
S
Niemann
Dirk
D
Holzinger
Johannes
J
Roth
Richard A
RA
Proctor
Karsten
K
Becker
Georg
G
Peters
Bettina
B
Löffler
D000818:Animals; D002460:Cell Line; D002908:Chronic Disease; D004195:Disease Models, Animal; D004734:Energy Metabolism; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D057131:Immune Evasion; D053858:Metabolic Networks and Pathways / Q000235:genetics; D051379:Mice; D008810:Mice, Inbred C57BL; D050296:Microbial Viability; D010586:Phagocytes / Q000382:microbiology*; D013203:Staphylococcal Infections / Q000276:immunology* / Q000382:microbiology*; D013211:Staphylococcus aureus / Q000254:growth & development / Q000276:immunology* / Q000378:metabolism / Q000472:pathogenicity*; D037521:Virulence Factors / Q000096:biosynthesis
D037521:Virulence Factors
Clin Infect Dis. 2006 Oct 15;43(8):961-7
16983605
Annu Rev Microbiol. 2010;64:357-72
20528688
J Infect Dis. 1998 Apr;177(4):1023-9
9534977
Nat Rev Immunol. 2008 Dec;8(12):958-69
19029990
J Infect Dis. 1996 Mar;173(3):739-42
8627043
J Infect Dis. 2010 Mar 15;201(6):871-80
20132035
Microbiology (Reading). 2008 Aug;154(Pt 8):2265-2274
18667559
BMC Microbiol. 2010 Jan 30;10:33
20113519
Clin Infect Dis. 1995 Jan;20(1):95-102
7727677
Bioorg Med Chem Lett. 2008 Jul 15;18(14):3860-4
18595694
Environ Microbiol. 2007 Dec;9(12):3134-42
17991040
Mol Microbiol. 2003 Jun;48(6):1429-49
12791129
J Bacteriol. 1997 Aug;179(15):4706-12
9244256
J Lab Clin Med. 1979 Aug;94(2):324-34
458250
J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):1000-2
12810807
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):4023-7
10097156
Science. 2004 Sep 10;305(5690):1622-5
15308767
J Infect Dis. 2010 Oct 1;202(7):1031-40
20715929
Infect Immun. 2005 Jul;73(7):4119-26
15972501
Nat Rev Microbiol. 2007 Jan;5(1):48-56
17143318
Infect Immun. 2002 Oct;70(10):5428-37
12228267
Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12541-6
20616060
J Clin Microbiol. 2009 Sep;47(9):2802-11
19605585
Cell Microbiol. 2010 Jan;12(1):10-8
19888990
Int J Antimicrob Agents. 2008 Jun;31(6):507-10
18180148
J Infect Dis. 2004 May 1;189(9):1574-84
15116292
Clin Infect Dis. 1999 Sep;29(3):621-5
10530458
BMC Genomics. 2007 Jun 14;8:171
17570841
N Engl J Med. 1998 Aug 20;339(8):520-32
9709046
Microb Pathog. 2010 Jan;48(1):18-27
19825410
Curr Opin Infect Dis. 2010 Aug;23(4):346-58
20592532
J Clin Invest. 1973 Nov;52(11):2745-56
4355998
J Lab Clin Med. 1984 Oct;104(4):455-69
6481212
FEMS Immunol Med Microbiol. 2005 Aug 1;45(2):245-52
15963705
Cell Microbiol. 2005 Aug;7(8):1087-97
16008576
Clin Microbiol Rev. 2010 Jul;23(3):616-87
20610826
Nat Rev Microbiol. 2006 Apr;4(4):295-305
16541137
J Mol Med (Berl). 2010 Jun;88(6):565-75
20151104
Curr Biol. 2001 Nov 13;11(22):1810-4
11719226
Nature. 2009 Feb 26;457(7233):1083
19242455
Clin Infect Dis. 1997 Nov;25(5):1250-1
9402396
Infect Immun. 2010 Aug;78(8):3392-403
20530231
J Clin Microbiol. 2006 Sep;44(9):3274-8
16954260
Trends Microbiol. 2009 Feb;17(2):54-8
19162480
N Engl J Med. 1993 Feb 11;328(6):422-8
8421461
Mol Microbiol. 2008 Dec;70(6):1540-55
19007412
Microbiol Rev. 1991 Dec;55(4):733-51
1779933
Nature. 2009 Nov 5;462(7269):90-3
19890329
Cell Microbiol. 1999 Sep;1(2):101-17
11207545
J Infect Dis. 1994 Oct;170(4):1033-7
7930701
Kidney Int. 2006 Sep;70(6):1089-98
16871245
J Antimicrob Chemother. 1997 May;39(5):603-8
9184359
J Infect. 2010 May;60(5):338-43
20230854
Rhinology. 2006 Dec;44(4):249-54
17216740
J Bacteriol. 2006 Jan;188(2):687-93
16385058
J Biol Chem. 2007 Jan 26;282(4):2695-706
17135247
J Bone Miner Res. 2002 Jun;17(6):979-86
12054173